Uncategorized


Comparative Benefits and Risks of Anti-Obesity Drugs

A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that anti-obesity medications vary substantially in both effectiveness and safety, with greater weight loss generally accompanied by higher rates of adverse events and treatment discontinuation. At one year, tirzepatide and cagrilintide-semaglutide (CagriSema) produced the greatest confirmed […]


Progestogen Contraceptives Linked to Increased Meningioma Risk

A nationwide Danish study found that recent use of several progestogen-containing contraceptives—including cyproterone, desogestrel, drospirenone, gestodene, levonorgestrel, injectable medroxyprogesterone, and high-dose levonorgestrel intrauterine devices (IUDs)—was associated with an increased risk of meningioma, with injectable medroxyprogesterone showing the strongest association. Researchers analyzed nationwide health registry data from approximately 3 million women […]


Coffee Consumption Linked to Lower Risk of Liver Disease

Higher coffee consumption was associated with substantially lower risks of cirrhosis, liver cancer, and liver-related death, while also showing favorable liver imaging and proteomic profiles in a prospective study of nearly 355,000 participants from the UK Biobank. During a median follow-up of 13 years, individuals who drank at least five […]


Sugar-Sweetened Beverages Linked to Higher Risk of Liver Cancer Subtypes

A pooled analysis of 11 prospective cohort studies involving more than 1.5 million adults found that higher consumption of sugar-sweetened beverages (SSBs) was associated with an increased risk of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), whereas artificially sweetened beverages (ASBs) were not associated with liver cancer risk. Researchers […]


ACS Updated Colorectal Cancer Screening Guidance

The American Cancer Society (ACS) reaffirmed that average-risk adults should begin colorectal cancer (CRC) screening at age 45 and continue through age 75 if life expectancy exceeds 10 years, while emphasizing that stool-based screening tests remain the preferred noncolonoscopy options over newer blood-based tests. CRC remains a leading cause of […]


Calcium and Vitamin D Supplements Provide Little Overall Protection Against Fractures and Falls

A comprehensive systematic review and meta-analysis involving 69 randomized controlled trials and 153,902 adults found that calcium supplements, vitamin D supplements, or their combination offer little to no clinically meaningful benefit in preventing fractures or falls in adults not taking osteoporosis medications. Most participants were community-dwelling individuals (87%) and were […]


Pros and Cons of PSA Screening for Prostate Cancer

An updated Cochrane systematic review of five randomized controlled trials involving 341,342 men found that PSA-based prostate cancer screening did not significantly reduce prostate cancer-specific mortality or overall mortality when all studies were combined, although one major European study (ERSPC) showed a 21% reduction in prostate cancer deaths among men […]